FrancophonIA/ELRC3.0 huggingface dataset:
English: Honey flavoured, white to off-white viscous oral suspension.
Maltese: Suspensjoni orali b' togħma ta' għasel, Bojod għal offwajt, suspensjoni orali viskużi
English: Granules in sachet
Maltese: Baqar, majjali u żwiemel
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Maltese: Il-frekwenza ta' effetti mhux mixtieqa hija definita skont din il-konvenzjoni: - komuni ħafna (aktar minn wieħed f'10 annimali trattati li juru effetti mhux mixtieqa) - komuni (aktar minn wieħed iżda inqas minn 10 annimali f'100 annimal trattati ) - mhux komuni (aktar minn wieħed iżda inqas minn10 annimali f'1,000 annimal trattati ) - rari (aktar minn wieħed iżda inqas minn10 annimali f'10,000 annimal trattati ) - rari ħafna (inqas minn annimal wieħed f'10,000 annimal trattati , inklużi rapporti iżolati).
English: Each ml contains: 1.5 mg of meloxicam, 5 mg of sodium benzoate.
Maltese: Kull ml fih: 1.5 mg ta' meloxicam 5 mg ta' sodium benzoate
English: Rheumocam 1 mg chewable tablets for dogs Rheumocam 2.5 mg chewable tablets for dogs
Maltese: FIL-PAKKETT Rheumocam 1 mg pilloli li jintmagħadu għall-klieb Rheumocam 2.5 mg pilloli li jintmagħadu għall-klieb
English: 21% of the recovered dose is eliminated in urine (2% as unchanged meloxicam, 19% as metabolites) and 79% in the faeces (49% as unchanged meloxicam, 30% as metabolites).
Maltese: L-osservazzjoni ta' metaboliti millkompost prinċipali fl-awrina u l-ippurgar, iżda mhux fil-plażma, hi indikattiva għat-tneħħija mgħaġġla tagħhom. 21% tad-doża rkuprata titneħħa fl-awrina (2% bħala meloxicam mhux mibdul, 19% bħala metaboliti) u 79% fl-ippurgar (49% bħala meloxicam mhux mibdul, 30% bħala metaboliti).
English: Active substance: Meloxicam
Maltese: Meloxicam Meloxicam Baqar Kaprini
English: 42, 100 or 200 ml polyethylene terephthalate (PET) bottle with a tamper resistant child proof closure, and a 15 ml HDPE bottle with a tamper resistant child proof closure, and two polypropylene measuring syringes: one for small dogs (up to 20 kg) and one for bigger dogs (up to 60 kg).
Maltese: Flixkun tal-polyethylene terephthalate (PET) ta' 42, 100 jew 200 ml b'tapp li jirrezisti tbagħbis u lftuħ mit-tfal, u flixkun ta' 15-il ml HDPE b'tapp li jirresisti tbagħbis u l-ftuħ mit-tfal, u żewġ siringi tal-polypropylene tal-kejl: waħda għall-klieb żgħar (sa 20 kg) u waħda għall-klieb akbar (sa 60 kg).
English: Pale yellow granules.
Maltese: Issintomi kienu riversibbli.
English: Interaction with other medicinal products and other forms of interaction: Other NSAIDs, diuretics, anti-coagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects.
Maltese: Interazzjoni ma' prodotti mediċinal oħrajn u forom oħrajn ta' interazzjoni NSAIDs oħra, dijuretiċi, antikoagulanti, antibijotiċi aminoglkosidi u sustanzi oħra li jabbinaw ħafna mal-proteini, jistgħu jikkompetu għall-abbinament u b'hekk iwasslu għal effetti tossiċi.
English: Rheumocam 0.5 mg/ml oral suspension for cats
Maltese: VETERINARJU Rheumocam 0.5 mg/ml suspensjoni orali għall-qtates
English: Rheumocam 1.5 mg/ml oral suspension for dogs or Rheumocam 1 mg and 2.5 mg chewable tablets for dogs may be used for continuation of treatment at a dosage of 0.1 mg meloxicam/kg body weight, 24 hours after administration of the injection.
Maltese: Rheumocam 1.5 mg/ml suspensjoni orali għall-klieb jew Rheumocam 1 mg u 2.5 mg pilloli li jintmagħadu għall-klieb jista' jintuża għat-tkomplija tat-trattament f'dożaġġ ta' 0.1 mg ta' meloxicam/kg ta' piż tal-ġisem, 24 siegħa wara l-għoti ta' l-injezzjoni.
English: In very rare cases, haemorrhagic diarrhoea, haematemesis, and gastrointestinal ulceration have been reported.
Maltese: F'każijiet rari ħafna, ġew irrapportati dijarea emorraġika, dijarea, ematemesi, ulċerazzjoni gastrointestinali u enżimi tal-fwied elevati.
English: PACKAGE LEAFLET: Rheumocam 20 mg/ml solution for injection for cattle, pigs and horses
Maltese: FIL-PAKKETT: Rheumocam 20 mg/ml soluzzjoni għall-injezzjoni għall-baqar, majjali u żwiemel.
English: The precision of the syringe is not suitable for the treatment of cats below 1 kg.
Maltese: Il-preċiżjoni tas-siringa mhix adatta għat-trattament talqtates ta' inqas minn 1 kg.
English: Single intravenous injection.
Maltese: Soluzzjoni għall-injezzjoni.
English: Meat and offal: 5 days.
Maltese: Laħam u ġewwieni ta' l-annimali: 5 ijiem.
English: Rheumocam 1.5 mg/ml oral suspension for dogs
Maltese: VETERINARJU Rheumocam 1.5 mg/ml suspensjoni orali għal klieb
English: Marker residue
Maltese: España Fatro
English: The excipients listed in section 6.1 of the SPC are either allowed substances for which table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required or are considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this product.
Maltese: Sustanzi mhux attivi elenkati fis-sezzjoni 6.1 tal-KPQ huma jew permessi sustanzi li għalihom tabella 1 tal-Anness għar-Regolament (UE) Nru 37/2010 tindika li għalihom mhumiex meħtieġa LMR jew huma kkunsidrati bħala li ma jaqgħux fl-ambitu tar-Regolament (KE) Nru 470/2009 meta użat bħal f'dan il-prodott.
English: {Carton for 10 ml, 20 ml and 100 ml vial}
Maltese: {Kartuna għal flixkun ta' 10 ml, 20 ml jew 100 ml}
English: Post operative pain associated with minor soft tissue surgery such as castration.
Maltese: Uġigħ ta' wara l-operazzjoni assoċjat ma' kirurġija minuri fuq tessut artab bħal kastrazzjoni.
English: Rheumocam 15 mg/ml oral suspension for horses
Maltese: Rheumocam 15 mg/ml suspensjoni orali għaż-żwiemel
English: People with known hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) should avoid contact with the veterinary medicinal product.
Maltese: Nies li huma sensittivi għal Mediċini Mhux Sterojdi Kontra l-Infjammazzjoni (NSAIDs) għandhom jevitaw li jmissu mal-prodott mediċinali veterinarju.
English: Active substance Meloxicam 0.5 mg
Maltese: Meloxicam 0.5 mg
English: Rheumocam 20 mg/ml solution for injection for cattle, pigs and horses Meloxicam
Maltese: Rheumocam 20 mg/ml soluzzjoni għall-injezzjoni għall-baqar, majjali u żwiemel. Meloxicam
English: Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, analgesic, anti-exudative and antipyretic effects.
Maltese: Meloxicam hu mediċina anti-infjammatorja mhux sterojdika (NSAID) tal-klassi oxicam li taġixxi blinibizzjoni tas-sintesi ta' prostaglandin, u b'hekk teżerċita effetti anti-infjammatorji, analġesiċi, kontra t-tnixxija u antipiretiċi.
English: Sachet
Maltese: Qtates
English: Alleviation of pain and inflammation in acute and chronic musculo-skeletal disorders in cats.
Maltese: Allevazzjoni ta' infjammazzjoni u wġigħ f'disturbi muskolu-skeletali akuti u kroniċi.
English: Puh/Tel: + 353 91 841788
Maltese: Galway Tel: + 353 91 841788
English: Meloxicam 5 mg Ethanol (96%) 159.8 mg Clear, yellow solution.
Maltese: Meloxicam 5 mg Ethanol (96%) 159.8 mg Soluzzjoni safra, ċara.
English: After a single subcutaneous dose of 0.5 mg meloxicam/kg, Cmax values of 2.1 μg/ml and 2.7 μg/ml were reached after 7.7 hours and 4 hours in young cattle and lactating cows, respectively.
Maltese: Wara l-għoti ta' doża waħda taħt il-ġilda ta' 0.5 mg ta' meloxicam/kg, intlaħqu valuri Cmax ta' 2.1 μg/ml u 2.7 μg/ml wara 7.7 sigħat u 4 sigħat f'baqar żgħar u f'baqar li jkunu qed ireddgħu, rispettivament.
English: Do not use in cats suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.
Maltese: Tużax fuq annimali li jsofru minn mard gastrointestinali, bħal irritazzjoni u emorraġija, li għandhom indeboliment fil-funzjoni epatika, kardijaka jew renali, u f'disturbi emorraġiċi.
English: Meloxicam 20 mg Ethanol (96 percent) 159.8 mg Clear, yellow solution.
Maltese: Meloxicam 20 mg Ethanol (96%) 159.8 mg Soluzzjoni safra ċara.
English: Cardboard box containing one colourless glass injection vial of 20 ml, 50 ml, 100 ml or 250 ml.
Maltese: Kaxxa tal-kartun b'kunjett wieħed tal-ħġieġ għall-injezzjoni ta' 20 ml, 50 ml, 100 ml jew 250 ml, mingħajr kulur.
English: Following subcutaneous administration, meloxicam is completely bioavailable and maximal mean plasma concentrations of 0.73 µg/ml in dogs and 1.1 μg/ml in cats were reached approximately 2.5 hours and 1.5 hours post administration, respectively.
Maltese: Wara l-għoti taħt il-ġilda, meloxicam hu kompletament bijodisponibbli, u l-ogħla medja ta' konċentrazzjonijiet fil-plażma ta' 0.73 g/ml, fil-klieb u 1.1 g/ml fil-qtates intlaħqu wara madwar 2.5 sigħat u 1.5 sigħat wara l-għoti rispettivament.
English: Single intramuscular injection at a dosage of 0.4 mg meloxicam/kg body weight (i.e. 2.0 ml/25 kg body weight).
Maltese: Injezzjoni waħda fil-muskolu b'dożaġġ ta' 0.4 mg ta' meloxicam / kg ta' piż tal-ġisem (i.e. 0,4 ml / 5 kg ta' piż tal-ġisem).
English: Meloxicam is a Non-Steroidal Anti-Inflammatory Drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, analgesic, anti-exudative and antipyretic effects.
Maltese: Meloxicam hi mediċina anti-infjammatorja mhux sterojdika (NSAID) tal-klassi oxicam li taġixxi billi tinibixxi s-sintesi ta' prostaglandin, u b'hekk teżerċita effetti anti-infjammatorji, analġesiċi, kontra ttnixxija u antipiretiċi.
English: Alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders in horses weighing between 500 and 600 kg.
Maltese: Allevazzjoni ta' infjammazzjoni u wġigħ f'disturbi muskolu-skeletali akuti u kroniċi fil-klieb.
English: Meloxicam 5 mg/ml.
Maltese: Meloxicam 5 mg
English: Disposal: read package leaflet.
Maltese: Is-suspensjoni tista' tingħata permezz tas-siringa tal-kejl ta' Rheumocam ipprovduta fil-pakkett.
English: Manufacturers responsible for the batch release: Chanelle Pharmaceuticals Manufacturing Ltd., Loughrea, Co. Galway,
Maltese: Manifattur Chanelle Pharmaceuticals Manufacturing Ltd., Loughrea, Co.
English: Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu/.
Maltese: Informazzjoni dettaljata dwar dan il-prodott mediċinali veterinarju tinstab fuq il-websajt ta' l-Aġenzija Ewropea għall-Mediċini http://www.ema.europa.eu/.
English: Cardboard box with 1 colourless glass injection vial containing 20 ml, 50 ml, 100 ml or 250 ml.
Maltese: Kaxxa tal-kartun b'kunjett wieħed tal-ħġieġ għall-injezzjoni, li jkun fih 20 ml, 50 ml, 100 ml jew 250 ml, mingħajr kulur.
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reactions) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated)
Maltese: Il-frekwenza ta' effetti mhux mixtieqa hija definita skont din il-konvenzjoni: - komuni ħafna (aktar minn wieħed f'10 annimali trattati li juru effetti mhux mixtieqa) - komuni (aktar minn wieħed iżda inqas minn 10 annimali f'100 annimal trattati ) - mhux komuni (aktar minn wieħed iżda inqas minn10 annimali f'1,000 annimal trattati )
English: To obtain the best possible pain relieving post surgery Rheumocam should be administered 30 minutes before surgical intervention.
Maltese: Biex tikseb l'aħjar effett possibbli biex jittafa l-uġigħ wara operazzjoni, Rheumocam għandu jingħata 30 minuta qabel intervent kirurġiku.
English: Rheumocam chewable tablets are supplied in:
Maltese: U KWANTITATTIVA Millitru wieħed fih:
English: Each chewable tablet contains: Active substance:
Maltese: Sustanza mhux attiva:
English: Each chewable tablet contains either 1 mg or 2.5 mg meloxicam, which corresponds to the daily maintenance dose for a 10 kg body weight dog, or a 25 kg body weight dog respectively.
Maltese: Kull pillola li tintmagħad fiha jew 1 mg jew 2.5 mg ta' meloxicam, li jikkorrispondu għal doża ta' manteniment ta' kuljum għal kelb li għandu piż tal- ġisem ta' 10kg jew 25 kg rispettivament.
English: Active substance: Meloxicam 15 mg
Maltese: Meloxicam 15mg
English: Each bottle is packed in a cardboard box with a 1 ml measuring syringe (barrel in polypropylene and plunger/piston in high density polyethylene).
Maltese: Kull flixkun huwa ppakkjat f'kaxxa tal-kartun b'siringa tal-kejl ta' ml (barmil fil-polypropylene u planġer / piston f'polyethylene ta' densità baxxa).
English: PACKAGE LEAFLET: Rheumocam 1.5 mg/ml oral suspension for dogs
Maltese: FIL-PAKKETT Rheumocam 1.5 mg/ml suspensjoni orali għall-klieb
English: Bovine, caprine
Maltese: DIKJARAZZJONI TAL-LMR
English: In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
Maltese: F'każ li tinjetta b'mod aċċidentali lilek innifsek, fittex parir mediku immedjatament u qis li turi ilfuljett ta' informazzjoni jew it-tikketta lit-tabib.
English: Typical adverse reactions of non-steroidal anti-inflammatory drugs (NSAIDs) such as loss of appetite, vomiting, diarrhoea, faecal occult blood lethargy and renal failure have occasionally been reported.
Maltese: Reazzjonijiet avversi tipiċi ta' Mediċini Mhux Sterojdi Kontra l-Infjammazzjoni (NSAIDs) bħal nuqqas ta' aptit, rimettar, dijarea, demm moħbi fl-ippurgar, letarġija u insuffiċjenza tal-kliewi ġew irrappurtati xi kultant.
English: BN {number}
Maltese: {Kartuna}
English: Saccharin sodium Carmellose sodium Silica, colloidal anhydrous Citric acid monohydrate Sorbitol, liquid (non-crystallising) Disodium phosphate dodecahydrate Sodium benzoate
Maltese: Kwalunkwe follow-up orali li bl-użu ta' meloxicam jew Mediċini Mhux Sterojdi Kontra lInfjammazzjoni (NSAIDs) oħrajn m'għandhomx jingħataw lill-qtates, minħabba li korsijiet adattati tad-dożaġġ għal dawn il-kuri follow-up ma kinux stabbiliti.
English: Clear yellow solution.
Maltese: Granul fil qartas.
English: - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Maltese: - rari (aktar minn wieħed iżda inqas minn10 annimali f'10,000 annimal trattati ) - rari ħafna (inqas minn annimal wieħed f'10,000 annimal trattati , inklużi rapporti iżolati).
English: Rheumocam 20 mg/ml solution for injection for cattle, pigs and horses
Maltese: Rheumocam 20 mg/ml soluzzjoni għall-injezzjoni għall-baqar, majjali u żwiemel.
English: {Carton for 20 ml, 50 ml and 100ml vial}
Maltese: {Kartuna għal flixkun ta' 20 ml, 50 ml jew 100 ml}
English: Rheumocam 0.5 mg/ml oral suspension for cats.
Maltese: Rheumocam 1.5 mg/ml suspensjoni orali għal klieb.
English: MANUFACTURER‟S BATCH NUMBER
Maltese: NUMRU TAL-LOTT TAL-MANIFATTUR
English: Do not use in animals suffering from impaired hepatic, cardiac or renal function and haemorrhagic disorders, or where there is evidence of ulcerogenic gastrointestinal lesions.
Maltese: F'każijiet rari ħafna, dijarea emorraġika, ematemesi u ulċerazzjoni gastrointestinali ġew irrappurtati.
English: Pharmacotherapeutic group: Anti-inflammatory and anti-rheumatic products, non-steroids (oxicams) ATCvet code: QM01AC06
Maltese: Prodotti anti-infjammatorji u anti-rewmatiċi, mhux sterojdiċi (oxicams)
English: {Label for 10 ml and 20 ml vials}
Maltese: {Tikketta għal fliexken ta' 10 ml u 20 ml}
English: Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders.
Maltese: Allevazzjoni ta' l-infjammazzjoni u ta' uġigħ sew akut u kroniku f'disturbi muskolu-skeletali.
English: PACKAGE LEAFLET: Rheumocam 5 mg/ml solution for injection for dogs and cats
Maltese: FIL-PAKKETT: Rheumocam 5 mg/ml soluzzjoni għall-injezzjoni għall-klieb u l-qtates..
English: The active substance in Rheumocam is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) 37/2010:
Maltese: Skont ir-Regolament tal-Kunsill (KE) Nru 37/2010, Rheumocam u huwa inkluż f'tabella numru 1 flAnness I tar-Regolament tal-Kunsill (KE) Nru 37/2010 kif imiss:
English: Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of increased renal toxicity.
Maltese: Evita l-użu fi kwalunkwe annimal li jkun deidratat, ipovolemiku jew ipotensiv, għax hemm riskju potenzjali ta' żieda ta' tossiċità renali.
English: 4 pre-filled syringes + 4 injection needles
Maltese: 4 siringi mimlijin għal-lest + 4 labar talinjezzjonijiet
English: 1 pre-filled syringe + 1 injection needle
Maltese: 1 siringa mimlija għal-lest + 1 labra talinjezzjoni
English: EMA/524629/2014 EMEA/H/C/001119
Maltese: EMEA/H/C/001119
English: Nevirapine Teva nevirapine
Maltese: Nevirapine Teva nevirapina
English: The full EPAR for Nevirapine Teva can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Maltese: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom increased to the full twice-daily dose until any rash has cleared.
Maltese: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom
English: The active substance in Nevirapine Teva, nevirapine, is a non-nucleoside reverse transcriptase inhibitor (NNRTI).
Maltese: Is-sustanza attiva f'Nevirapine Teva, in-nevirapina, hija inibitur mhux nukleosidiku tat-transkrittażi inversa (non-nucleoside reverse transcriptase inhibitor, NNRTI).
English: Nevirapine Teva is an antiviral medicine.
Maltese: Nevirapine Teva huwa mediċina antivirali.
English: The European Commission granted a marketing authorisation valid throughout the EU for Nevirapine Teva on 30 November 2009.
Maltese: Il-Kummissjoni Ewropea tat awtorizzazzjoni għat-tqegħid fis-suq valida fl-UE kollha għal Nevirapine Teva fit-30 ta' Novembru 2009.
English: This is a summary of the European public assessment report (EPAR) for Nevirapine Teva.
Maltese: Dan huwa sommarju tar-rapport pubbliku Ewropew ta' valutazzjoni (EPAR) għal Nevirapine Teva.
English: Nevirapine Teva is a ‘generic medicine'.
Maltese: NevirapineTeva huwa ‘mediċina ġenerika'.
English: Nevirapine Teva is a medicine that contains the active substance nevirapine.
Maltese: Nevirapine Teva huwa mediċina li fiha s-sustanza attiva nevirapina.
English: It is used in combination with other antiviral medicines to treat patients infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS).
Maltese: Jintuża flimkien ma' mediċinali antivirali oħra biex jikkura pazjenti infettati bil-virus tal-immunodefiċjenza umana (HIV) tat-tip 1, virus li jikkawża s-sindromu mill-immunodefiċjenza akkwiżita (AIDS).
English: The CHMP concluded that, in accordance with EU requirements, Nevirapine Teva has been shown to have comparable quality and to be bioequivalent to Viramune.
Maltese: Is-CHMP kkonkluda li, b'mod konformi mar-rekwiżiti tal-UE, intwera li Nevirapine Teva għandu kwalità komparabbli u huwa bijoekwivalenti għal Viramune.
English: Because Nevirapine Teva is a generic medicine, studies have been limited to tests to determine that it is bioequivalent to the reference medicine, Viramune.
Maltese: Billi Nevirapine Teva huwa mediċina ġenerika, l-istudji ġew limitati għal testitjiet biex jiddeterminaw ilbijoekwivalenza tiegħu mal-mediċina ta' referenza, Viramune.
English: This means that Nevirapine Teva is similar to a ‘reference medicine' already authorised in the European Union (EU) called Viramune.
Maltese: Dan ifisser li Nevirapine Teva huwa simili għall-‘mediċina ta' referenza' diġà awtorizzata fl-Unjoni Ewropea (UE) bl-isem Viramune.
English: Other information about Nevirapine Teva
Maltese: Aktar informazzjoni dwar Nevirapine Teva
English: By blocking this enzyme, Nevirapine Teva, taken in combination with other antiviral medicines, reduces the amount of HIV-1 in the blood and keeps it at a low level.
Maltese: Billi jimblokka din l-enzima, Nevirapine Teva, meħud flimkien ma' mediċini antivirali oħra, inaqqas l-ammont ta' HIV-1 fid-demm u jżommu f'livell baxx.
English: What are the benefits and risks of Nevirapine Teva?
Maltese: X'inhuma l-benefiċċji u r-riskji ta' Nevirapine Teva?
English: Nevirapine Teva does not cure HIV-1 infection or AIDS, but it may delay the damage to the immune system and the development of infections and diseases associated with AIDS.
Maltese: Nevirapine Teva ma jfejjaqx infezzjoni mill-HIV jew tal-AIDS, iżda jista' jittardja l-ħsara lis-sistema immunitarja u l-iżvilupp ta' infezzjonijiet u mard assoċjat mal-AIDS.
English: What is Nevirapine Teva?
Maltese: Għal xiex jintuża Nevirapine Teva?
English: Because Nevirapine Teva is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as the reference medicine.
Maltese: Peress li Nevirapine Teva huwa mediċina ġenerika u huwa bijoekwivalenti għall-mediċina ta' referenza, il-benefiċċji u r-riskji tiegħu jitqiesu li kienu l-istess bħal dawk tal-mediċina ta' referenza.
English: It blocks the activity of reverse transcriptase, an enzyme produced by HIV-1 that allows it to infect cells in the body and make more viruses.
Maltese: Din timblokka l-attività tattranskrittażi inversa, enzima prodotta mill-HIV-1 li tħalliha tinfetta ċ-ċelloli fil-ġisem u tirriproduċi ruħha.
English: Because the medicine can cause serious rash, treatment starts with 200 mg once a day for two weeks, before increasing the dose to the standard dose of 200 mg twice a day.
Maltese: Peress li l-mediċina tista' tikkaġuna raxx gravi, il-kura għandha tinbeda b'200 mg darba kuljum għal ġimagħtejn, qabel ma d-doża tiżdied għad-doża standard ta' 200 mg darbtejn kuljum.
English: Why has Nevirapine Teva been approved?
Maltese: Għaliex ġie approvat Nevirapine Teva?
English: Estrada do Rio da Mó , nº 8, 8-A e 8-B Fervença, Terrugem SNT, 2705-906 Portugal
Maltese: Estrada do Rio da Mó, nº 8, 8-A e 8-B Fervença, Terrugem SNT, 2705-906 Il-Portugall
English: - Urticaria.
Maltese: - Urtikarja.
English: Date of latest renewal: 24.05.2017
Maltese: Data tal-aħħar tiġdid: 24.05.2017
English: 1.0 mg/dl or 88 μmol/l.
Maltese: 1.0 mg/dl jew 88 µmol/l.
English: MYLAN PHARMACEUTICALS Sp. z o.o.
Maltese: MYLAN PHARMACEUTICALS Sp. z o.o. ul.
English: Multipack: 4 vials (4 packs of 1)
Maltese: Pakkett multiplu: 4 kunjetti (4 pakketti ta' 1)
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 23.08.2012
Maltese: DATA TAL-EWWEL AWTORIZZAZZJONI/TIĠDID TAL-AWTORIZZAZZJONI Data tal-ewwel awtorizzazzjoni: 23.08.2012
English: 117 allée des Parcs 69800 SAINT-PRIEST France
Maltese: MYLAN S.A.S 117 allée des Parcs 69800 SAINT-PRIEST FRANZA
English: Acute renal failure, haematuria, proteinuria Acquired Fanconi syndrome
Maltese: Insuffiċjenza renali, ħematurja, proteinurja Sindrome Fanconi Akkwiżita
English: Zoledronic acid recommended dose* 4.0 mg zoledronic acid 3.5 mg* zoledronic acid 3.3 mg* zoledronic acid 3.0 mg* zoledronic acid *Doses have been calculated assuming target AUC of 0.66 (mg•hr/l) (CLcr=75 ml/min).
Maltese: 4.0 mg zoledronic acid 3.5 mg* zoledronic acid 3.3 mg* zoledronic acid 3.0 mg* zoledronic acid * Id-dożi ġew ikkalkulati billi tqieset mira ta' AUC ta' 0.66 (mg•hr/l) (CLcr = 75 ml/min).
English: Table 6: Adverse reactions observed in paediatric patients with severe osteogenesis imperfecta1 Nervous system disorders
Maltese: Tabella 6: Reazzjonijiet avversi osservati f'pazjenti pedjatriċi b'osteoġenesi imperfetta severa1
English: Interaction with other medicinal products and other forms of interaction
Maltese: Interazzjonijiet ma' prodotti mediċinali oħra u forom oħra ta' interazzjoni
English: List of excipients
Maltese: Lista ta' eċċipjenti